8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Hyperplasia in 1 studies
8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battalora, MS | 1 |
| Johnston, DA | 1 |
| DiGiovanni, J | 1 |
1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Hyperplasia
| Article | Year |
|---|---|
The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthracenes; Calcium; Calcium Channel Blockers; Carcinoge | 1995 |